Erratum: Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type v Polysaccharide (Bioconjugate Chemistry (2015) 26:8 (1839-1849) DOI: 10.1021/acs.bioconjchem.5b00365);Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type v Polysaccharide

Bioconjugate Chemistry

Volumn 26, Issue 8, 2015, Pages 1839-1849

  Nilo, Alberto ^a   Passalacqua, Irene ^a   Fabbrini, Monica ^a   Allan, Martin ^b   Usera, Aimee ^b   Carboni, Filippo ^a   Brogioni, Barbara ^a   Pezzicoli, Alfredo ^a   Cobb, Jennifer ^b   Romano, Maria Rosaria ^a   Margarit, Immaculada ^a   Hu, Qi Ying ^b   Berti, Francesco ^a   Adamo, Roberto ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIBODIES; ANTIGENS; BIOSYNTHESIS; COPPER COMPOUNDS; STRAIN; T-CELLS; VACCINES;

CAPSULAR POLYSACCHARIDES; DUAL ROLE; GLYCOCONJUGATE VACCINES; GROUP B STREPTOCOCCUS; IMMUNOGENICITY; LYSINE RESIDUES; MALEIMIDES; MICROBIAL TRANSGLUTAMINASE; PROTEIN CONJUGATES; [3+2]-CYCLOADDITION;

POLYSACCHARIDES;

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; GBS67 PILUS PROTEIN; GLYCOCONJUGATE; LYSINE; MALEIMIDE DERIVATIVE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; STREPTOCOCCUS VACCINE; TYPE V POLYSACCHARIDE; TYROSINE; UNCLASSIFIED DRUG; BACTERIAL VACCINE; POLYSACCHARIDE; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIUM PILUS; CATALYSIS; CONTROLLED STUDY; CYCLOADDITION; DRUG CONJUGATION; DRUG SYNTHESIS; IMMUNIZATION; MICHAEL ADDITION; MOUSE; NONHUMAN; STREPTOCOCCUS AGALACTIAE; AMINO ACID SEQUENCE; ANIMAL; CARBOHYDRATE ANALYSIS; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; MOLECULAR GENETICS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

MUS; STREPTOCOCCUS SP. 'GROUP B';

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CARBOHYDRATE SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOCONJUGATES; IMMUNIZATION; MICE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TYROSINE; VACCINES, CONJUGATE;

EID: 84939616116     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.5b00480     Document Type: Erratum

References (42)

1. Avci, F. Y. and Kasper, D. L. (2010) How bacterial carbohydrates influence the adaptive immune system Annu. Rev. Immunol. 28, 107-110 10.1146/annurev-immunol-030409-101159
2. Berti, F. and Adamo, R. (2013) Recent mechanistic insights on glycoconjugate vaccines and future perspectives ACS Chem. Biol. 8, 1653-1663 10.1021/cb400423g
3. Costantino, P., Rappuoli, R., and Berti, F. (2011) The design of semi-synthetic and synthetic glycoconjugate vaccines Expert Opin. Drug Discovery 6, 1045-1067 10.1517/17460441.2011.609554
4. Spicer, C. D. and Davis, B. G. (2014) Selective chemical protein modification, Nat. Commun. 5, DOI: 10.1038/ncomms5740.
5. Stephanopoulos, N. and Francis, M. B. (2011) Choosing an effective protein bioconjugation strategy Nat. Chem. Biol. 7, 876-883 10.1038/nchembio.720
6. Boutureira, O. and Bernardes, G. J. L. (2015) Advances in chemical Protein Modification Chem. Rev. 115, 2174 10.1021/cr500399p
7. Rostovtsev, V. V., Green, L. G., Fokin, V. V., and Sharpless, K. B. (2002) A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed regioselective ligation of azides and terminal lkynes Angew. Chem., Int. Ed. 41, 2596-2599 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
8. Tørnoe, C. W., Christensen, C., and Meldal, M. (2002) Peptidotriazoles on solid phase: [1,2,3]-Triazoles by regiospecific Copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides J. Org. Chem. 67, 3057-3064 10.1021/jo011148j
9. Hu, Q.-Y., Allan, M., Adamo, R., Quinn, D., Zhai, H., Wu, G., Clark, K., Zhou, J., Ortiz, S., Wang, B., and Danieli, E. et al. 2013, Synthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy Chem. Sci. 4, 3827-3832 10.1039/c3sc51694f
10. Adamo, R., Martin, A., Berti, B., Danieli, E., and Hu, Q.-Y. (2013) Tyrosine ligation process and crosslinking agents used to form tyrosine-contg. polypeptide conjugates for raising an immune response in a mammal., PCT Int. Appl. WO 2013009564 A2013009561 2020130117.
11. Adamo, R., Hu, Q.-Y., Torosantucci, A., Crotti, S., Brogioni, G., Allan, M., Chiani, P., Bromuro, C., Quinn, D., and Tontini, M. et al. 2014, Deciphering the structure-immunogenicity relationship of anti-Candida glycoconjugate vaccines Chem. Sci. 5, 4302-4311 10.1039/C4SC01361A
12. Zaleznik, D. F., Rench, M. A., Hillier, S., Krohn, M. A., Platt, R., Lee, M. T., Flores, A. E., Ferrieri, P., and Baker, C. J. (2000) Invasive disease due to Group B Streptococcus in pregnant women and neonates from diverse population groups Clin. Infect. Dis. 30, 276-281 10.1086/313665
13. Baker, C. J., Rench, M. A., Edwards, M. S., Carpenter, R. J., Hays, B. M., and Kasper, D. L. (1988) Immunization of pregnant women with a polysaccharide vaccine of Group B streptococcus N. Engl. J. Med. 319, 1180-1185 10.1056/NEJM198811033191802
14. Madoff, L. C., Paoletti, L. C., and Kasper, D. L. (2006) Surface structures of Group B streptococci important in human immunity, In Gram-Positive Pathogens, 2 nd ed. (Fischetti, V. A., Novick, R. P., Ferretti, J. J., Portnoy, D. A., and Rood, J. I., Eds.) pp 169-185, American Society of Microbiologists: Washington, DC.
15. Berti, F., Campisi, E., Toniolo, C., Morelli, L., Crotti, S., Rosini, R., Romano, M. R., Pinto, V., Brogioni, B., and Torricelli, G. et al. 2014, Structure of the type IX Group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII J. Biol. Chem. 289, 23437-23448 10.1074/jbc.M114.567974
16. Heath, P. T. and Feldman, R. G. (2005) Vaccination against Group B streptococcus Expert Rev. Vaccines 4, 207-218 10.1586/14760584.4.2.207
17. Rappuoli, R. (2000) Reverse vaccinology Curr. Opin. Microbiol. 3, 445-450 10.1016/S1369-5274(00)00119-3
18. Maione, D., Margarit, I., Rinaudo, C. R., Masignani, V., Mora, M., Scarselli, M., Tettelin, H., Brettoni, C., Iacobini, E. T., and Rosini, R. et al. 2005, Identification of a universal Group B Streptococcus vaccine by multiple genome screen Science 309, 148-150 10.1126/science.1109869
19. Nilo, A., Allan, M., Brogioni, B., Proietti, D., Cattaneo, V., Crotti, S., Sokup, S., Zhai, H., Margarit, I., and Berti, F. et al. 2014, Tyrosine-directed conjugation of large glycans to proteins via copper-free click chemistry Bioconjugate Chem. 25, 2105-2111 10.1021/bc500438h
20. Agard, N. J., Baskin, J. M., Prescher, J. A., Lo, A., and Bertozzi, C. R. (2006) A comparative study of bioorthogonal reactions with azides ACS Chem. Biol. 1, 644-648 10.1021/cb6003228
21. Jewett, J. C. and Bertozzi, C. R. (2010) Cu-free click cycloaddition reactions in chemical biology Chem. Soc. Rev. 39, 1272-1279 10.1039/b901970g
22. Lauer, P., Rinaudo, C. D., Soriani, M., Margarit, I., Maione, D., Rosini, R., Taddei, A. R., Mora, M., Rappuoli, R., Grandi, G., and Telford, J. L. (2005) Genome analysis reveals pili in Group B Streptococcus Science 309, 105 10.1126/science.1111563
23. Rosini, R., Rinaudo, C. D., Soriani, M., Lauer, P., Mora, M., Maione, D., Taddei, A., Santi, I., Ghezzo, C., and Brettoni, C. et al. 2006, Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae Mol. Microbiol. 61, 126-141 10.1111/j.1365-2958.2006.05225.x
24. Nilo, A., Morelli, L., Passalacqua, I., Brogioni, B., Allan, M., Carboni, F., Pezzicoli, A., Maione, D., Fabbrini, M., and Romano, M. R. et al. 2015, Anti-Group B Streptococcus carbohydrate-based vaccines using pilus proteins as carriers: Comparing lysine and tyrosine-directed conjugation ACS Chem. Biol. 10, 1737 10.1021/acschembio.5b00247
25. Davies, D. L., Raj, S., Adair, C., Robinson, J., and McGeer, A. (2001) Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation Pediatr. Infect. Dis. J. 20, 879-884 10.1097/00006454-200109000-00011
26. Baker, C. J., Rench, M. A., Paoletti, L. C., and Edwards, M. S. (2007) Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults Vaccine 25, 55-63 10.1016/j.vaccine.2006.07.018
27. Hendrickx, A. P. A., Budzik, J. M., Oh, S.-Y., and Schneewind, O. (2011) Architects at the bacterial surface-sortases and the assembly of pili with isopeptide bonds Nat. Rev. Microbiol. 9, 166-176 10.1038/nrmicro2520
28. Margarit, I., Rinaudo, C. R., Galeotti, C. L., Maione, D., Ghezzo, C., Buttazzoni, E., Rosini, R., Runci, Y., Mora, M., and Buccato, S. et al., (2009) Preventing bacterial infections with pilus-based vaccines: the Group B Streptococcus paradigm, J. Infect. Dis. 199, 108, DOI: 10.1086/595564
29. Schmaltz, R. M., Hanson, S. R., and Wong, C.-H. (2011) Enzymes in the synthesis of glycoconjugates Chem. Rev. 111, 4259-4307 10.1021/cr200113w
30. Rabuka, D. (2010) Chemoenzymatic methods for site-specific protein modification Curr. Opin. Chem. Biol. 14, 790-796 10.1016/j.cbpa.2010.09.020
31. Jeger, S., Zimmermann, K., Blanc, A., Grunberg, J., Honer, M., Hunziker, P., Struthers, H., and Schibli, R. (2010) Site-Specific and stoichiometric modification of antibodies by bacterial Transglutaminase Angew. Chem., Int. Ed. 49, 9995-9997 10.1002/anie.201004243
32. Dennler, P., Chiotellis, A., Fischer, E., Brégeon, D., Belmant, C., Gauthier, L., Lhospice, F., Romagne, F., and Schibli, R. (2014) Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates Bioconjugate Chem. 25, 569-578 10.1021/bc400574z
33. Bauer, D. M., Ahmed, I., Vigovskaya, A., and Fruk, L. (2013) Clickable tyrosine binding bifunctional linkers for preparation of DNA-protein conjugates Bioconjugate Chem. 24, 1094-1101 10.1021/bc4001799
34. Cal, P. M. S. D., Bernardes, G. J. L., and Gois, P. M. P. (2014) Cysteine-selective reactions for antibody conjugation Angew. Chem., Int. Ed. 53, 10585-10587 10.1002/anie.201405702
35. Verez-Bencomo, V., Fernandez-Santana, V., Hardy, E., Toledo, M. E., Rodrlguez, M. C., Heynngnezz, L., Rodriguez, A., Baly, A., Herrera, L., and Izquierdo, M. et al. 2004, A Synthetic conjugate polysaccharide vaccine against Haemophilus influenzae Type b Science 305, 522-525 10.1126/science.1095209
36. 197 Nucleic Acids Res. 12, 4063-4069 10.1093/nar/12.10.4063
37. Wessels, M. R., Paoletti, L. C., Kasper, D. L., DiFabio, J. L., Michon, F., Holme, K., and Jennings, H. J. (1990) Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against Type III Group B Streptococcus J. Clin. Invest. 86, 1428-1433 10.1172/JCI114858
38. Guttormsen, H., Liu, Y., and Paoletti, L. C. (2008) Functional activity of antisera to group B streptococcal conjugate vaccines measured with an opsonophagocytosis assay and HL-60 effector cells Hum. Vaccines 4, 370-374 10.4161/hv.4.5.5988
39. Brigtsen, A. K., Kasper, D. L., Baker, C. J., Jennings, H. J., and Guttormsen, H. (2002) J. Infectious Dis. 185, 1277-1284
40. Yin, Z., Nguyen, H. G., Chowdhury, S., Bentley, P., Bruckman, M. A., Miermont, A., Gildersleeve, J. C., Wang, Q., and Huang, X. (2012) Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens Bioconjugate Chem. 23, 1694-1703 10.1021/bc300244a
41. Buskas, T., Li, Y., and Boons, G. J. (2004) The immunogenicity of the tumor-associated antigen Lewisy may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein Chem.-Eur. J. 10, 3517-3524 10.1002/chem.200400074
42. Costantino, P., Norelli, F., Giannozzi, A., D'Ascenzi, S., Bartoloni, A., Kaur, S., Tang, D., Seid, R., Viti, S., and Paffetti, R. et al. 1999, Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines Vaccine 17, 1251-1263 10.1016/S0264-410X(98)00348-X